Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2019 Apr 25;380(17):1667-1668.
doi: 10.1056/NEJMe1904140. Epub 2019 Apr 10.

Can Immune Checkpoint Inhibitors Keep JC Virus in Check?

Affiliations
Editorial

Can Immune Checkpoint Inhibitors Keep JC Virus in Check?

Igor J Koralnik. N Engl J Med. .

Comment on

  • Treatment of Progressive Multifocal Leukoencephalopathy with Nivolumab.
    Walter O, Treiner E, Bonneville F, Mengelle C, Vergez F, Lerebours F, Delobel P, Liblau R, Martin-Blondel G; Immune Checkpoint Inhibitors in PML Study Group. Walter O, et al. N Engl J Med. 2019 Apr 25;380(17):1674-1676. doi: 10.1056/NEJMc1816198. Epub 2019 Apr 10. N Engl J Med. 2019. PMID: 30969500 No abstract available.
  • Pembrolizumab Treatment for Progressive Multifocal Leukoencephalopathy.
    Cortese I, Muranski P, Enose-Akahata Y, Ha SK, Smith B, Monaco M, Ryschkewitsch C, Major EO, Ohayon J, Schindler MK, Beck E, Reoma LB, Jacobson S, Reich DS, Nath A. Cortese I, et al. N Engl J Med. 2019 Apr 25;380(17):1597-1605. doi: 10.1056/NEJMoa1815039. Epub 2019 Apr 10. N Engl J Med. 2019. PMID: 30969503 Clinical Trial.
  • Treatment of Progressive Multifocal Leukoencephalopathy with Pembrolizumab.
    Rauer S, Marks R, Urbach H, Warnatz K, Nath A, Holland S, Weiller C, Grimbacher B. Rauer S, et al. N Engl J Med. 2019 Apr 25;380(17):1676-1677. doi: 10.1056/NEJMc1817193. Epub 2019 Apr 10. N Engl J Med. 2019. PMID: 30969507 No abstract available.

Similar articles

See all similar articles

Cited by 4 articles

LinkOut - more resources

Feedback